Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $881.93 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $390.85 | 9 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $125.00 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $109.07 | 3 | $0 (2020) |
| Abbott Laboratories | $64.78 | 1 | $0 (2021) |
| Aurinia Pharma U.S., Inc. | $53.21 | 1 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $44.55 | 4 | $0 (2019) |
| NxStage Medical, Inc. | $16.13 | 1 | $0 (2021) |
| Relypsa, Inc. | $15.78 | 1 | $0 (2019) |
| Biohaven Pharmaceuticals, Inc. | $13.31 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12.67 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53.21 | 1 | Aurinia Pharma U.S., Inc. ($53.21) |
| 2023 | $14.80 | 1 | Fresenius USA Marketing, Inc. ($14.80) |
| 2022 | $13.54 | 1 | Fresenius USA Marketing, Inc. ($13.54) |
| 2021 | $219.22 | 4 | Bayer HealthCare Pharmaceuticals Inc. ($125.00) |
| 2020 | $85.54 | 1 | AstraZeneca Pharmaceuticals LP ($85.54) |
| 2019 | $249.28 | 6 | Fresenius USA Marketing, Inc. ($222.14) |
| 2018 | $186.44 | 7 | Fresenius USA Marketing, Inc. ($140.37) |
| 2017 | $59.90 | 5 | AstraZeneca Pharmaceuticals LP ($23.53) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/23/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $53.21 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 04/13/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug), KORSUVA | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/14/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/18/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardio-renal | ||||||
| 07/28/2021 | NxStage Medical, Inc. | PUREFLOW SL (Device), NXSTAGE SYSTEM ONE | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Nephrology | ||||||
| 07/01/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $64.78 | General |
| Category: Heart Failure | ||||||
| 03/08/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: PRIMARY CARE | ||||||
| 10/20/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $85.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/10/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/10/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $0.38 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/30/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: DIABETES | ||||||
| 04/04/2019 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $96.07 | General |
| 04/03/2019 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $113.93 | General |
| 03/29/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Hyperkalemia | ||||||
| 12/16/2018 | Lilly USA, LLC | HUMULIN (Drug), TRULICITY | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Diabetes | ||||||
| 11/20/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: DIABETES | ||||||
| 09/18/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: DIABETES | ||||||
| 02/22/2018 | Fresenius USA Marketing, Inc. | Not Product Related (Medical Supply) | Food and Beverage | In-kind items and services | $53.87 | General |
| 02/22/2018 | Fresenius USA Marketing, Inc. | Not Product Related (Medical Supply) | Food and Beverage | In-kind items and services | $50.70 | General |
| 02/22/2018 | Fresenius USA Marketing, Inc. | Not Product Related (Medical Supply) | Food and Beverage | In-kind items and services | $35.80 | General |
| 01/22/2018 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Nephrology | ||||||
| 12/19/2017 | Keryx Biopharmaceuticals, Inc. | Auryxia (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Nephrology | ||||||
| 08/17/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/29/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: DIABETES | ||||||
| 06/06/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,257 | 2,511 | $897,737 | $271,335 |
| 2022 | 16 | 1,311 | 2,826 | $1.1M | $320,652 |
| 2021 | 16 | 1,360 | 2,942 | $975,956 | $313,108 |
| 2020 | 17 | 2,024 | 4,777 | $1.4M | $395,641 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Facility | 2023 | 60 | 349 | $323,949 | $91,745 | 28.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 145 | 711 | $118,737 | $41,704 | 35.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Facility | 2023 | 61 | 166 | $127,424 | $36,150 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 219 | 281 | $68,564 | $24,774 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 212 | 272 | $66,368 | $19,712 | 29.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 51 | 120 | $28,680 | $10,632 | 37.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 102 | 110 | $34,650 | $10,525 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 121 | 129 | $21,285 | $7,562 | 35.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 51 | 53 | $24,539 | $6,845 | 27.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 39 | 117 | $30,654 | $6,130 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 100 | 104 | $17,160 | $4,999 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $13,838 | $3,799 | 27.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 19 | $6,232 | $2,247 | 36.1% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Facility | 2023 | 14 | 14 | $7,405 | $2,098 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 14 | $4,592 | $1,491 | 32.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $3,660 | $923.41 | 25.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Facility | 2022 | 69 | 449 | $413,387 | $121,121 | 29.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 186 | 760 | $124,650 | $40,509 | 32.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Facility | 2022 | 50 | 137 | $104,763 | $30,565 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 247 | 418 | $97,972 | $27,984 | 28.6% |
| 90966 | Home dialysis services per month (20 years or older) | Facility | 2022 | 17 | 93 | $70,866 | $20,658 | 29.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 111 | 117 | $52,605 | $16,997 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 153 | 164 | $39,956 | $15,297 | 38.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 49 | 126 | $29,962 | $9,554 | 31.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 50 | 67 | $21,273 | $7,027 | 33.0% |
About Dr. Yuvaraj Thangaraj, MD
Dr. Yuvaraj Thangaraj, MD is a Internal Medicine healthcare provider based in Mason City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215943063.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yuvaraj Thangaraj, MD has received a total of $881.93 in payments from pharmaceutical and medical device companies, with $53.21 received in 2024. These payments were reported across 26 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($881.93).
As a Medicare-enrolled provider, Thangaraj has provided services to 5,952 Medicare beneficiaries, totaling 13,056 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Mason City, IA
- Active Since 08/01/2006
- Last Updated 07/14/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1215943063
Products in Payments
- Not Product Related (Medical Supply) $140.37
- Kerendia (Drug) $125.00
- LOKELMA (Drug) $85.54
- CardioMEMS HF System (Device) $64.78
- LUPKYNIS (Drug) $53.21
- Velphoro (Drug) $40.48
- FARXIGA (Drug) $23.53
- SOLIQUA (Drug) $21.44
- PUREFLOW SL (Device) $16.13
- Veltassa (Drug) $15.78
- NURTEC ODT (Drug) $13.31
- JARDIANCE (Drug) $12.67
- HUMULIN (Drug) $12.49
- Parsabiv (Biological) $12.14
- Auryxia (Drug) $11.95
- PRALUENT (Drug) $11.75
- SOLIQUA 100/33 (Drug) $11.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mason City
Mark Johnson, Md, MD
Internal Medicine — Payments: $380,856
Dr. Rodrigo Erlich, M.d, M.D
Internal Medicine — Payments: $54,026
Dr. Richard Rattin, D.o, D.O
Internal Medicine — Payments: $14,533
Sepideh Darbandi, Do, DO
Internal Medicine — Payments: $8,241
Dr. Michael Spooner, M.d, M.D
Internal Medicine — Payments: $7,144
Noor Subah, Md, MD
Internal Medicine — Payments: $5,819